DEMUSTIN 100 MG

País: Israel

Idioma: anglès

Font: Ministry of Health

ingredients actius:

BENDAMUSTINE HYDROCHLORIDE

Disponible des:

RAFA LABORATORIES LTD

Codi ATC:

L01AA09

formulario farmacéutico:

POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION

Composición:

BENDAMUSTINE HYDROCHLORIDE 100 MG/VIAL

Vía de administración:

I.V

tipo de receta:

Required

Fabricat per:

INTAS PHARMACEUTICALS LTD, INDIA

Área terapéutica:

BENDAMUSTINE

indicaciones terapéuticas:

First-line treatment of chronic lymphocytic leukaemia (Binet stage B or C) in patients for whom fludarabine combination chemotherapy is not appropriate.Indolent non-Hodgkin’s lymphomas as monotherapy in patients, who have progressed during or within 6 months following treatment with rituximab or a rituximab containing regimen.Follicular non-Hodgkin’s lymphoma as first line treatment in combination with rituximab.

Data d'autorització:

2018-01-31